Validation of TNM Classification for Metastatic Prostatic Cancer Treated Using Primary Androgen Deprivation Therapy

World Journal of Urology - Germany
doi 10.1007/s00345-015-1607-3
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Differential Use of Medical Versus Surgical Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer

Journal of Urology
Urology
2011English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Androgen Deprivation Therapy for Prostate Cancer—review of Indications in 2010

Current Oncology
Oncology
2010English

Real-World Incidence and Burden of Adverse Events Among Non-Metastatic Prostate Cancer Patients Treated With Secondary Hormonal Therapies Following Androgen Deprivation Therapy

Journal of Medical Economics
Health Policy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy